Evidence map›Paper›PMID 31797114›Full record

ArticleMikrochimica acta2019

An anti-BSA antibody-based immunochromatographic assay for chloramphenicol and aflatoxin M

Zhiwei Qie, Wenliang Yan, Zichen Gao, Wu Meng, Rui Xiao, Shengqi Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhiwei QieBeijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Wenliang YanBeijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Zichen GaoCenter for Diseases Prevention and Control of Rocket Force, Beijing, 100095, People's Republic of China.
Wu MengCenter for Diseases Prevention and Control of Rocket Force, Beijing, 100095, People's Republic of China.
Rui XiaoBeijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China. ruixiao203@sina.com.
Shengqi WangBeijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China. sqwang@bmi.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A lateral-flow immunochromatographic assay with excellent sensitivity and wide application potential is described. The bovine serum albumin (BSA) antibody was immobilized in the test line for universality, and preincubation was introduced for high method sensitivity. Carboxy-modified CdSe/ZnS core-shell nanoparticles were used as label, and the fluorescence peaking at 605 nm was detected. The fluorescence in the test line was negative against the relevant analyte content. The chloramphenicol (CAP) and the aflatoxin M

Indexed as

Aflatoxin M1Antibodies, ImmobilizedCadmium CompoundsChloramphenicolImmunoassayLimit of DetectionNanoparticlesSelenium CompoundsSerum Albumin, BovineSulfidesZinc CompoundsAflatoxin M1Antibodies, ImmobilizedCadmium Compoundscadmium selenideChloramphenicolSelenium CompoundsSerum Albumin, BovineSulfidesZinc Compoundszinc sulfideCompetitive recognitionImmunoassayMilkMycotoxinPre-incubationSensitivityUniversality

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.